<DOC>
	<DOCNO>NCT00650611</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability oral ziprasidone child teens psychotic disorder</brief_summary>
	<brief_title>A Study Safety Tolerability Oral Ziprasidone Children Teens With Psychotic Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Children teens Bipolar I Disorder ( manic mixed ) , schizophrenia schizoaffective disorder Willingness discontinue antipsychotic medication study period Patients clinically stable treatment well tolerate Substanceinduced psychotic disorder</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>